2025-08-01 - Analysis Report
Okay, here's the analysis of Eli Lilly and Co (LLY), presented as a report with key numbers, analysis, and considerations.

**Report: Eli Lilly and Co (LLY) Analysis**

**Company Overview:** Eli Lilly and Co. is a global pharmaceutical company that develops and markets medicines across a broad range of therapeutic areas.

**1. Performance vs. S&P 500 (VOO)**

*   **LLY Cumulative Return:** 205.52%
*   **VOO Cumulative Return:** 83.19%
*   **Absolute Deviation:** 147.7
*   **Relative Deviation:** 51.6

**Analysis:** LLY has significantly outperformed the S&P 500.  The relative deviation of 51.6 suggests LLY's outperformance is positioned roughly in the middle range of its historical deviation from the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2015-2017  | 1.0%   | 0.0%   | -2.0%   | -0.1   | 75.8   |
| 2016-2018  | 27.0%  | 58.6%  | 32.0%   | 0.0    | 103.9  |
| 2017-2019  | 41.0%  | 58.6%  | 18.0%   | 0.0    | 118.0  |
| 2018-2020  | 53.0%  | 58.6%  | 26.0%   | 0.0    | 151.6  |
| 2019-2021  | 104.0% | 60.6%  | 55.0%   | 0.0    | 248.0  |
| 2020-2022  | 96.0%  | 65.0%  | 89.0%   | 0.1    | 328.4  |
| 2021-2023  | 129.0% | 65.0%  | 109.0%  | 0.2    | 523.3  |
| 2022-2024  | 145.0% | 72.0%  | 119.0%  | 0.2    | 693.0  |
| 2023-2025  | 68.0%  | 76.8%  | 20.0%   | 0.2    | 664.4  |

**Analysis:**

*   **CAGR:**  CAGR(Compound Annual Growth Rate) is generally high, indicating strong growth over the periods analyzed.
*   **MDD:** MDD(Maximum Drawdown) is also quite high.
*   **Alpha:** Positive and substantial alpha values ​​indicate that LLY's excess return compared to the benchmark is high.
*   **Beta:** The beta has increased slightly over time, indicating that LLY is becoming more sensitive to market fluctuations.
*   **Cap:** Market capitalization has grown significantly over time.

**2. Recent Price Action**

*   **Current Price:** 740.07
*   **Last Market Data:** Price: 740.07, Previous Close: 760.08, Change: -2.63% (significant drop)
*   **5-day Moving Average:** 776.78
*   **20-day Moving Average:** 781.52
*   **60-day Moving Average:** 769.17

**Analysis:** The current price is below all three moving averages, indicating potential short-term downward momentum. The recent -2.63% change suggests a notable negative event or sentiment shift impacted the stock.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3295 (Low Risk)
*   **RSI:** 38.14 (Approaching Oversold)
*   **PPO:** -0.53 (Negative Momentum)
*   **Hybrid Signal:** Cash 60%_Sell 59.7% of holdings
*   **Recent (20-day) Relative Deviation Change:** +0.8 (Short-term Increase)
*   **Expected Return:** 152.2% (Long-Term, vs. S&P 500)

**Analysis:**

*   The MRI indicates a low-risk environment.
*   The RSI is approaching oversold territory, suggesting a potential bounce.
*   PPO indicates negative momentum.
*   The hybrid signal suggests selling some shares and maintaining a high cash position, indicating a cautious outlook.
*   Despite recent price drops, the expected return is very high, suggesting long-term confidence in LLY's growth potential.

**4. Recent News & Significant Events**

*   **2025-08-01:** Major business developments, regulatory changes, or market events (Source: Example News)
*   **2025-07-29:** Analyst discussions on performance, industry trends, and global economic factors (Source: Example Finance)
*   **2025-07-30:** Stock volatility influenced by news, earnings, or executive actions (Source: Example Markets)
*   **2025-07-28:** Expert advice to monitor news and announcements for risks and opportunities (Source: Example Analyst)

**Analysis:** Recent news suggests volatility and potential risks/opportunities.  It's crucial to investigate the specific developments driving these headlines.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-05-01 | 3.07 | 12.73 B$ |
| 2024-10-30 | 1.08 | 11.44 B$ |
| 2024-08-08 | 3.29 | 11.30 B$ |
| 2024-04-30 | 2.49 | 8.77 B$  |
| 2025-05-01 | 2.49 | 8.77 B$ |

**Analysis:** Earnings per share(EPS) and sales figures have generally increased recently.
A steady increase in EPS and sales figures indicates continued growth in Lilly's business.

**6. Financial Information**

Revenue and Profitability:

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $12.73B   | 82.53%        |
| 2024-12-31 | $13.53B   | 82.24%        |
| 2024-09-30 | $11.44B   | 81.02%        |
| 2024-06-30 | $11.30B   | 80.80%        |
| 2024-03-31 | $8.77B    | 80.91%        |

Capital and Profitability:

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $15.76B   | 17.50%    |
| 2024-12-31 | $14.19B   | 31.07%    |
| 2024-09-30 | $14.24B   | 6.81%     |
| 2024-06-30 | $13.56B   | 21.88%    |
| 2024-03-31 | $12.81B   | 17.51%    |

**Analysis:**

*   **Revenue:**  Revenue has generally trended upward.
*   **Profit Margin:** Consistently high profit margins.
*   **Equity:** Equity has increased steadily.
*   **ROE:** Return on Equity (ROE) is variable, but generally indicates good profitability (especially the 31.07% in Dec 2024).

**7. Overall Summary & Considerations**

Eli Lilly and Co. (LLY) has demonstrated significant outperformance relative to the S&P 500, with strong historical growth reflected in its CAGR and alpha.  Recent price action suggests a short-term pullback, potentially driven by news or events causing volatility. While technical indicators present a mixed picture (oversold RSI, negative PPO, cautious hybrid signal), the long-term expected return remains very high.

**Key Considerations:**

*   **Recent Volatility:** Investigate the specific news or events driving the recent price decline and volatility. Assess if these are temporary setbacks or indicative of longer-term challenges.
*   **Hybrid Signal:** Understand the reasoning behind the "cash 60% / sell" signal. Is it related to market conditions, company-specific factors, or a combination of both?
*   **Long-Term Growth Drivers:** LLY's high expected return suggests strong confidence in its future growth. Identify the key products, pipeline developments, or market opportunities driving this optimism.
*   **Risk Factors:** High MDD.

In conclusion, LLY presents a compelling investment case, driven by historical outperformance and strong long-term growth prospects. However, investors should carefully consider the recent volatility, technical signals, and underlying risk factors before making any decisions.
